Gapping up
In reaction to earnings/guidance:
- HZO +30.1%, SLM +22.1%, TER +9.2%, PTC +8.8%, STM +7.2%, CTXS +4.3%, STLD +4%, BANC +3.6%, JBLU +3.1%, MTB +2.4%, CMCSA +2.1%, KMI +1.2%, UMPQ +0.8%, KMB +0.8%
Other news:
- EYE +8.4% (amended Walmart management & services agreement adding new vision centers)
- PCG +4.9% (reaches agreement with ad hoc noteholder committee; to support PG&E's plan of reorganization)
- PAYC +4.5% (to join S&P 500)
- BHVN +2.1% (Biohaven Pharmaceutical collaborators receive FDA approval to proceed with clinical investigation of verdiperstat in ALS)
- ELAN +1.1% (priced its previously announced concurrent public offerings of 22,694,732 shares of its common stock at $32.00/share)
Analyst comments:
- LB +4.7% (upgraded to Overweight from Underweight at Barclays)
- WDC +3.3% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- GE +2.3% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- ASC +2% (upgraded to Buy from Hold at Stifel)
- MU +1.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- SAN +1% (upgraded to Buy from Neutral at UBS)